Manulife (Manufacturers Life Insurance)’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.48M | Sell |
263,334
-1,179
| -0.4% | -$33.5K | 0.01% | 977 |
|
|
2025
Q1 | $7.81M | Buy |
264,513
+208
| +0.1% | +$6.14K | 0.01% | 958 |
|
|
2024
Q4 | $7.69M | Buy |
264,305
+6,849
| +3% | +$199K | 0.01% | 1014 |
|
|
2024
Q3 | $11.8M | Sell |
257,456
-15,306
| -6% | -$703K | 0.01% | 812 |
|
|
2024
Q2 | $11.1M | Buy |
272,762
+42,636
| +19% | +$1.74M | 0.01% | 794 |
|
|
2024
Q1 | $5.87M | Buy |
230,126
+71,519
| +45% | +$1.83M | 0.01% | 1118 |
|
|
2023
Q4 | $1.44M | Buy |
158,607
+16,343
| +11% | +$148K | ﹤0.01% | 1624 |
|
|
2023
Q3 | $908K | Sell |
142,264
-680
| -0.5% | -$4.34K | ﹤0.01% | 1789 |
|
|
2023
Q2 | $1.59M | Buy |
142,944
+7,005
| +5% | +$77.7K | ﹤0.01% | 1479 |
|
|
2023
Q1 | $2.09M | Buy |
135,939
+849
| +0.6% | +$13K | ﹤0.01% | 1389 |
|
|
2022
Q4 | $3.05M | Buy |
135,090
+43,622
| +48% | +$985K | ﹤0.01% | 1277 |
|
|
2022
Q3 | $1.52M | Sell |
91,468
-483
| -0.5% | -$8.04K | ﹤0.01% | 1455 |
|
|
2022
Q2 | $1.32M | Buy |
91,951
+9,835
| +12% | +$141K | ﹤0.01% | 1531 |
|
|
2022
Q1 | $1.49M | Buy |
82,116
+62,375
| +316% | +$1.13M | ﹤0.01% | 1584 |
|
|
2021
Q4 | $472 | Sell |
19,741
-26
| -0.1% | -$1 | ﹤0.01% | 2298 |
|
|
2021
Q3 | $487K | Buy |
19,767
+2,770
| +16% | +$68.2K | ﹤0.01% | 2308 |
|
|
2021
Q2 | $420K | Sell |
16,997
-24
| -0.1% | -$593 | ﹤0.01% | 2564 |
|
|
2021
Q1 | $371K | Buy |
17,021
+7,310
| +75% | +$159K | ﹤0.01% | 2477 |
|
|
2020
Q4 | $248K | Buy |
9,711
+823
| +9% | +$21K | ﹤0.01% | 2630 |
|
|
2020
Q3 | $250K | Buy |
+8,888
| New | +$250K | ﹤0.01% | 2421 |
|